Worldwide Publications of Interest

• Optimizing diagnostic tools and outcomes evaluation for t(9;22)-positive leukemias in pediatric low middle-income country (LMIC) patients
  Bukhari SI et al. Cancer Invest, January 2025 (epub ahead of print)
• Bringing global hematology research to the forefront
  Gómez-De León A et al. Blood Adv, July 2024
• Estimating prognostic relevant cutoff values for a multiplex PCR detecting BCR::ABL1 in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy in resource-limited settings
  Hailu S et al. Ann Hematol, May 2023 – open access publication
• Precision medicine in low- and middle-income countries
  Radich JP et al. Annu Rev Pathol, January 2022
• Analysis of the gap in PCR monitoring availability for patients with chronic myeloid leukemia in 60 low- and middle-income countries
  Rowley S et al. Cost Eff Resour Allo, March 2021 – open access publication

• Global, regional, and national burden of chronic myeloid leukemia, 1990-2017: A systematic analysis of the Burden of Disease Study 2017
  Lin Q et al. Front Oncol, December 2020 – open access publication
• Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study
  Ning L et al. Exp Hematol Oncol, November 2020 – open access publication
• Molecular testing of chronic myeloid leukemia in low resource areas
  Radich J. Br J Haematol, July 2020 (epub ahead of print)
• The survival of patients enrolled in a global direct-to-patient cancer medicine donation program: The Glivec International Patient Assistance Program (GIPAP)
  Chukwuemeka A. Umeh et al, EClinicalMedicine, January 2020 - open access publication
• Meeting the needs of CML patients in resource-poor countries
  Malhotra H et al. Hematology Am Soc Hematol Educ Program, December 2019
• Cost and quality issues in establishing hematopoietic cell transplant program in developing countries
  Hashmi SK et al. Hematol Oncol Stem Cell Thera, July 2017
• Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years of 32 Cancer Groups, 1990 to 2015: A systematic analysis for the global burden of disease study
  Global Burden of Disease Collaboration, JAMA Oncol, April 2017
• Meta-prediction of MTHFR gene polyphormism-mutations, air pollution, and risks of leukemia among world populations
  Lien SA et al. Oncotarget, January 2017